Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$251.88 - $324.2 $1.36 Million - $1.76 Million
-5,417 Closed
0 $0
Q3 2020

Nov 17, 2020

SELL
$255.22 - $317.0 $2.29 Million - $2.84 Million
-8,958 Reduced 62.32%
5,417 $1.5 Million
Q2 2020

Aug 13, 2020

SELL
$141.4 - $257.09 $1.06 Million - $1.92 Million
-7,475 Reduced 34.21%
14,375 $3.47 Million
Q1 2020

May 18, 2020

SELL
$130.51 - $196.01 $4.61 Million - $6.92 Million
-35,314 Reduced 61.78%
21,850 $3.17 Million
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $1.78 Million - $2.5 Million
11,175 Added 24.3%
57,164 $9.75 Million
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $7.64 Million - $12.1 Million
43,414 Added 1685.98%
45,989 $8.18 Million
Q2 2019

Aug 13, 2019

BUY
$250.96 - $284.94 $646,222 - $733,720
2,575 New
2,575 $671,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Grandeur Peak Global Advisors, LLC Portfolio

Follow Grandeur Peak Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.